Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 4/20 | 0.74 |
| ▸ | MAOA | P21397 | 2/20 | 0.74 |
| ▸ | CA12 | O43570 | 3/20 | 0.70 |
| ▸ | CA9 | Q16790 | 3/20 | 0.70 |
| ▸ | CA2 | P00918 | 2/20 | 0.70 |
| ▸ | CA3 | P07451 | 2/20 | 0.70 |
| ▸ | CA4 | P22748 | 2/20 | 0.70 |
| ▸ | CA6 | P23280 | 2/20 | 0.70 |
| ▸ | CA7 | P43166 | 2/20 | 0.70 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.70 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | USP2 | O75604 | 2/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.63 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.63 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.63 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.63 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.63 |
| ▸ | MIF | P14174 | 1/20 | 0.62 |
| ▸ | PFKFB3 | Q16875 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21585388 | 0.89 | MIF (0.74) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL25697207 | 0.87 | MAOB (0.63) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL30595106 | 0.86 | MAOB (0.78) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL11486663 | 0.86 | MAOB (0.78) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL6417829 | 0.85 | MAOB (1.00) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL18752370 | 0.85 | CA12 (0.85) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL1808756 | 0.85 | MAOA (0.71) | MAOACA12CA9CA2CA3 | |
| SCHEMBL25213073 | 0.84 | MAOB (0.74) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL11485550 | 0.84 | MAOB (0.74) | MAOBMAOACA12CA9CA2 | |
| SCHEMBL25207493 | 0.84 | MAOB (0.74) | MAOBMAOACA12CA9CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117794266-A | Hole transport layer, perovskite solar cell, and preparation method and application thereof | 中国科学院化学研究所 | 2024-03-29 | — | — | CN | disclosed |
| EP-2902388-B1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY INC (CN) | 2019-03-13 | — | — | EP | disclosed |
| CN-104144919-B | Theanine derivatives and the condensation product of carboxylic acid coumarin derivative and its intermediate, preparation method and use | 山东营东颖昊生物科技有限公司 | 2018-07-03 | — | — | CN | disclosed |
| US-9518038-B2 | Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) | 2016-12-13 | — | — | US | disclosed |
| US-9518038-B2 | Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) | 2016-12-13 | — | — | US | disclosed |
| US-9518038-B2 | Condensation product of theanine derivative and carboxylic acid coumarin derivative, its intermediate, preparation method and use thereof | SHANDONG YINGDONG YINGHAO BIOTECHNOLOGY, INC. (CN) | 2016-12-13 | — | — | US | disclosed |
| US-9492418-B2 | Inhibitors of PFKFB3 for cancer therapy | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2016-11-15 | — | — | US | disclosed |
| US-9492418-B2 | Inhibitors of PFKFB3 for cancer therapy | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2016-11-15 | — | — | US | disclosed |
| EP-2295053-B1 | Novel 2H-chromen-2-one-3-carboxamides for medical uses | INST MATERIA MEDICA CAMS (CN) | 2016-10-19 | — | — | EP | disclosed |
| CN-103626730-B | A kind of preparation method of Coumarin-3-carboxylic ester derivant | 安徽师范大学 | 2016-08-17 | — | — | CN | disclosed |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | ZHANG, GUOYING (CN) | 2015-08-27 | — | — | US | disclosed |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | ZHANG, GUOYING (CN) | 2015-08-27 | — | — | US | disclosed |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | ZHANG, GUOYING (CN) | 2015-08-27 | — | — | US | disclosed |
| EP-2902388-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | Yantai University (CN) | 2015-08-05 | — | — | EP | disclosed |
| EP-2902388-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, INTERMEDIATE OF THE CONDENSATION PRODUCT, METHOD FOR PREPARING SAME, AND USE THEREOF | Yantai University (CN) | 2015-08-05 | — | — | EP | disclosed |
| CN-103690528-A | Application of ethyl 6-bromocoumarin-3-carboxylyl L-theanine and the like in preparation of product used for preventing and treating disease such as cancers | UNIV YANTAI | 2014-04-02 | — | — | CN | disclosed |
| CN-103626730-A | Preparation method for coumarin-3-carboxylic ester derivative | UNIV ANHUI NORMAL | 2014-03-12 | — | — | CN | disclosed |
| US-20120302631-A1 | Inhibitors of PFKFB3 for Cancer Therapy | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2012-11-29 | — | — | US | disclosed |
| US-20120302631-A1 | Inhibitors of PFKFB3 for Cancer Therapy | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE | 2012-11-29 | — | — | US | disclosed |
| US-4201783-A | Antidepressant substituted hexahydro benzopyrano [3,2-c] pyridines | LIPHA LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) | 1980-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302631-A1 | Inhibitors of PFKFB3 for Cancer Therapy | PFKFB3, PFKFB2, PFKFB1 | MAOB 2055/4885MAOA 3633/4885CA12 3682/4885 |
| US-20150239861-A1 | CONDENSATION PRODUCT OF THEANINE DERIVATIVE AND CARBOXYLIC ACID COUMARIN DERIVATIVE, ITS INTERMEDIATE, PREPARATION METHOD AND USE THEREOF | OGDH, C9, IRAK3 | MAOB 2720/4885MAOA 3987/4885CA12 1593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.